• EN
  • DE
Onkopti - Onkologische Therapieprotokolle Online
  • Home
    • Protocols
    • Examples
    • News
    • About Onkopti
    • Licenses
    • App Installation
    • Contact
  • Diseases
  • Protocol search
  • Licenses
    • Online and PDF-Export
    • Import to BD Cato™
    • Import in MS Excel
    • Import to J-Med
    • Import to Omniplaner
    • Import to oncotrace
    • Individual file import in XML format
  • Login
  • Register
  • EN
    • DE
Select Page
Back New search Go to results

Disease

Chemotherapy

 Radiotherapy

Supportive therapy

Protocol classification

 only studies

Publication

Protocols in Revision
14 protocols found
Protocols under revision.
Azathioprine 2, Autoimmune Hemolytic Anemia, warm type (PID2008 V1.0)
Bortezomib 1,3, Autoimmune Hemolytic Anemia, Cold Agglutinin Disease (PID2023 V1.0)
Cyclophosphamide 50, Autoimmune Hemolytic Anemia, warm type (PID2016 V1.0)
Daratumumab 1800, Autoimmune Hemolytic Anemia, Warm Type and Cold Agglutinin Disease (PID2864 V1.0)
Mycophenolate Mofetil (500/1000), Autoimmune Hemolytic Anemia, warm type (PID2014 V1.0)
Prednisolone (1.5/0.75/0.5) / Rituximab 375, Autoimmune Hemolytic Anemia, warm type (PID2007 V1.0)
Prednisolone (1.5/0.75/0.5), Autoimmune Hemolytic Anemia, warm type (PID2006 V1.0)
Prednisolone 1 / Rituximab 1000, Autoimmune Hemolytic Anemia, warm type (PID2015 V1.0)
Prednisolone 5 / Ciclosporin (2.5/1.5), Autoimmune Hemolytic Anemia, warm type (PID2013 V1.0)
Rituximab 375 / Bendamustine 90, Autoimmune Hemolytic Anemia / Cold Agglutinin Disease (PID1089 V1.2)
Rituximab 375 / Fludarabine 25, Autoimmune Hemolytic Anemia, Cold Agglutinin Disease (PID2022 V1.0)
Rituximab 375, Autoimmune Hemolytic Anemia, Cold Agglutinin Disease (PID2005 V1.0)
Sutimlimab 6.5, Autoimmune Hemolytic Anemia, Cold Agglutinin Disease, Cycle 1. (PID2248 V1.0)
Sutimlimab 6.5, Autoimmune Hemolytic Anemia, Cold Agglutinin Disease, Cycle 2+. (PID2249 V1.0)
  • Copyright, Trademark
  • App Installation
  • Disclaimer
  • Conditions
  • Payment Methods
  • Privacy policy
  • Imprint